Revolutionary Genome Sequencing Technologies The $1000 Genome (R21)

The summary for the Revolutionary Genome Sequencing Technologies The $1000 Genome (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Revolutionary Genome Sequencing Technologies The $1000 Genome (R21)
	CFDA Number:	93.172
	CFDA Description:	Human Genome Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-HG-10-013
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Aug 27, 2010
	Creation Date:	Aug 27, 2010
	Original Closing Date for Applications:	Oct 17, 2012
	Current Closing Date for Applications:	Oct 17, 2012
	Archive Date:	Nov 17, 2012
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Non-domestic (non-U.S.) Entities (Foreign Organizations).
Grant Description: Purpose. The National Human Genome Research Institute (NHGRI) solicits R21 grant applications to develop novel technologies that will enable extremely low-cost, high quality DNA sequencing. The goal of this initiative is to reduce the cost of sequencing a mammalian-sized genome to approximately $1000. Applicants may propose to develop full-scale sequencing systems or to investigate challenges underlying key system components. Exploration of methods other than those currently being pursued as potential $1,000 genome technologies are encouraged. High-risk/high-payoff proposals are appropriate to achieve the goals of this FOA by approximately 2014. Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Research (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, RFA-HG-10-012 and RFA-HG-10-014, that encourage applications under the R01 and R43/R44 mechanisms. Funds Available and Anticipated Number of Awards. Contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications, the NHGRI may make 2-7 awards and may award $2 million total costs in each of FY2011, FY 2012, and FY 2013 in response to this FOA.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-hg-10-013.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • NIH Small Research Grant Program (Parent R03); • NIH Exploratory/Developmental Research Grant Program (Parent R21); • Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Researc...; • The Electronic Medical Records and Genomics (eMERGE) Network, Phase II Pediatric Study Investigators...; • Technology Development for High-Throughput Functional Genomics (R21); • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - STTR (R41/R42); • A Data Coordination Center for the Knockout Mouse Project (KOMP)